Oxford Biomedica. 2005 to see 'Huge value creation' (Panmure Gordon)

Well true, no Xmas sell off last year then a good rise in January, no doubt each year different newsflow has to determine different situations. We can't assume Jan06 will be the same.
However! the SP should return to the 'old' price (before the fund raising less the difference cased by the dilution).
that figure is 33-34p, But: we now have a different situation, no need for funding OR a J/V, Teovax goes into Phase III, so becomes considerably mnore valuable 'intellectual property' wise. So the Brokers note of 40p target
( without any new deals of course) is entirerly reasonable.